Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ethanol | 6 | 2023 | 325 | 1.180 |
Why?
|
| Hepatitis, Alcoholic | 7 | 2023 | 78 | 1.160 |
Why?
|
| Receptors, CCR2 | 2 | 2020 | 13 | 0.810 |
Why?
|
| Macrophages | 6 | 2022 | 1053 | 0.710 |
Why?
|
| Central Nervous System Depressants | 2 | 2018 | 46 | 0.690 |
Why?
|
| Brain | 2 | 2020 | 1581 | 0.680 |
Why?
|
| Receptors, CCR5 | 1 | 2020 | 59 | 0.640 |
Why?
|
| Liver Diseases, Alcoholic | 5 | 2019 | 91 | 0.620 |
Why?
|
| Inflammasomes | 3 | 2023 | 342 | 0.600 |
Why?
|
| Fatty Liver | 2 | 2017 | 109 | 0.590 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2023 | 260 | 0.580 |
Why?
|
| Encephalitis | 1 | 2018 | 36 | 0.570 |
Why?
|
| Sex Characteristics | 1 | 2020 | 202 | 0.560 |
Why?
|
| Neutrophil Infiltration | 2 | 2017 | 61 | 0.530 |
Why?
|
| Microglia | 1 | 2020 | 250 | 0.530 |
Why?
|
| Mice, Inbred C57BL | 12 | 2020 | 3450 | 0.520 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 316 | 0.510 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2018 | 252 | 0.490 |
Why?
|
| Inflammation | 4 | 2023 | 1162 | 0.450 |
Why?
|
| Cytokines | 1 | 2018 | 944 | 0.430 |
Why?
|
| Hepatocytes | 6 | 2022 | 220 | 0.350 |
Why?
|
| Signal Transduction | 3 | 2020 | 3070 | 0.340 |
Why?
|
| CCR5 Receptor Antagonists | 2 | 2020 | 16 | 0.310 |
Why?
|
| Mice | 12 | 2023 | 11003 | 0.300 |
Why?
|
| Fatty Liver, Alcoholic | 3 | 2019 | 33 | 0.280 |
Why?
|
| Animals | 15 | 2023 | 20962 | 0.270 |
Why?
|
| MicroRNAs | 3 | 2019 | 697 | 0.260 |
Why?
|
| Autophagy | 2 | 2019 | 231 | 0.250 |
Why?
|
| Female | 15 | 2024 | 33351 | 0.240 |
Why?
|
| Psychomotor Agitation | 1 | 2024 | 19 | 0.210 |
Why?
|
| Clinical Alarms | 1 | 2024 | 12 | 0.210 |
Why?
|
| Hepatitis | 1 | 2023 | 58 | 0.190 |
Why?
|
| Anti-Bacterial Agents | 2 | 2018 | 800 | 0.180 |
Why?
|
| Macrophage Activation | 2 | 2019 | 119 | 0.170 |
Why?
|
| Headache | 1 | 2021 | 58 | 0.170 |
Why?
|
| Dyspnea | 1 | 2021 | 124 | 0.170 |
Why?
|
| Sulfoxides | 1 | 2020 | 17 | 0.170 |
Why?
|
| Imidazoles | 1 | 2020 | 84 | 0.160 |
Why?
|
| para-Aminobenzoates | 1 | 2020 | 2 | 0.160 |
Why?
|
| Liver Cirrhosis, Alcoholic | 2 | 2019 | 19 | 0.160 |
Why?
|
| Indenes | 1 | 2020 | 15 | 0.160 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2020 | 23 | 0.160 |
Why?
|
| Sulfones | 1 | 2020 | 41 | 0.160 |
Why?
|
| Furans | 1 | 2020 | 33 | 0.160 |
Why?
|
| Cough | 1 | 2021 | 182 | 0.150 |
Why?
|
| Dipeptides | 1 | 2020 | 68 | 0.150 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 178 | 0.150 |
Why?
|
| Acute-Phase Proteins | 1 | 2019 | 34 | 0.150 |
Why?
|
| Sulfonamides | 1 | 2020 | 131 | 0.150 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 34 | 0.140 |
Why?
|
| Exosomes | 1 | 2019 | 52 | 0.140 |
Why?
|
| Lysosomes | 1 | 2019 | 169 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2012 | 727 | 0.140 |
Why?
|
| Extracellular Traps | 1 | 2018 | 44 | 0.140 |
Why?
|
| Antigens, CD | 1 | 2019 | 348 | 0.140 |
Why?
|
| Binge Drinking | 1 | 2018 | 37 | 0.140 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2019 | 91 | 0.130 |
Why?
|
| Intestines | 1 | 2018 | 169 | 0.130 |
Why?
|
| Kupffer Cells | 1 | 2017 | 43 | 0.130 |
Why?
|
| Phagocytosis | 1 | 2018 | 266 | 0.130 |
Why?
|
| Histone Deacetylases | 1 | 2017 | 66 | 0.130 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2012 | 508 | 0.130 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 97 | 0.130 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 2238 | 0.130 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2016 | 53 | 0.120 |
Why?
|
| Syk Kinase | 1 | 2016 | 9 | 0.120 |
Why?
|
| Oxazines | 1 | 2016 | 13 | 0.120 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 49 | 0.120 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2016 | 97 | 0.120 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2016 | 53 | 0.120 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2016 | 34 | 0.120 |
Why?
|
| Membrane Glycoproteins | 1 | 2019 | 671 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 544 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2024 | 1118 | 0.120 |
Why?
|
| Pyridines | 1 | 2016 | 114 | 0.120 |
Why?
|
| Cell Death | 1 | 2016 | 286 | 0.110 |
Why?
|
| Liver Cirrhosis | 1 | 2016 | 180 | 0.110 |
Why?
|
| Disease Progression | 1 | 2019 | 1176 | 0.110 |
Why?
|
| Carrier Proteins | 1 | 2019 | 709 | 0.110 |
Why?
|
| Sepsis | 1 | 2018 | 290 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 181 | 0.110 |
Why?
|
| Bacteria | 1 | 2017 | 317 | 0.100 |
Why?
|
| Time Factors | 2 | 2018 | 3724 | 0.100 |
Why?
|
| Gene Expression | 1 | 2017 | 851 | 0.100 |
Why?
|
| Middle Aged | 5 | 2024 | 17899 | 0.100 |
Why?
|
| RNA, Messenger | 1 | 2018 | 1551 | 0.090 |
Why?
|
| Lipopolysaccharides | 3 | 2022 | 624 | 0.090 |
Why?
|
| Liver | 1 | 2017 | 868 | 0.090 |
Why?
|
| Profilins | 1 | 2012 | 45 | 0.090 |
Why?
|
| Mutant Proteins | 1 | 2012 | 105 | 0.090 |
Why?
|
| Male | 8 | 2024 | 30295 | 0.090 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2011 | 11 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2019 | 1130 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 1196 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2016 | 909 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 1621 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2011 | 134 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2017 | 1540 | 0.080 |
Why?
|
| Humans | 10 | 2024 | 64244 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2011 | 387 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 458 | 0.060 |
Why?
|
| Cell Proliferation | 2 | 2022 | 1001 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2017 | 351 | 0.060 |
Why?
|
| Hypnotics and Sedatives | 1 | 2024 | 65 | 0.050 |
Why?
|
| Mutation | 1 | 2012 | 2629 | 0.050 |
Why?
|
| Benzodiazepines | 1 | 2024 | 102 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2024 | 163 | 0.050 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2023 | 70 | 0.050 |
Why?
|
| Caspase 1 | 1 | 2023 | 112 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2022 | 36 | 0.050 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2022 | 41 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2023 | 271 | 0.040 |
Why?
|
| Antipsychotic Agents | 1 | 2024 | 304 | 0.040 |
Why?
|
| Aged | 3 | 2024 | 14648 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2016 | 2176 | 0.040 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2019 | 9 | 0.040 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2019 | 14 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2019 | 40 | 0.040 |
Why?
|
| Adult | 3 | 2024 | 17117 | 0.040 |
Why?
|
| Palmitic Acid | 1 | 2019 | 15 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 113 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2019 | 125 | 0.040 |
Why?
|
| ROC Curve | 1 | 2019 | 288 | 0.040 |
Why?
|
| HMGB1 Protein | 1 | 2018 | 26 | 0.040 |
Why?
|
| Cause of Death | 1 | 2019 | 222 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 423 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2019 | 587 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 735 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 313 | 0.030 |
Why?
|
| RAW 264.7 Cells | 1 | 2017 | 55 | 0.030 |
Why?
|
| Carbon Tetrachloride | 1 | 2016 | 11 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 930 | 0.030 |
Why?
|
| Monocytes | 1 | 2019 | 356 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2019 | 471 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 205 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 209 | 0.030 |
Why?
|
| Diethylnitrosamine | 1 | 2016 | 2 | 0.030 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2016 | 15 | 0.030 |
Why?
|
| alpha-Fetoproteins | 1 | 2016 | 15 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 2016 | 45 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 1102 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2017 | 614 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 443 | 0.030 |
Why?
|
| Endotoxins | 1 | 2016 | 82 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 1769 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1561 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 901 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 1431 | 0.030 |
Why?
|
| Neutrophils | 1 | 2016 | 378 | 0.020 |
Why?
|
| United States | 2 | 2019 | 7923 | 0.020 |
Why?
|
| Jews | 1 | 2012 | 10 | 0.020 |
Why?
|
| Growth Cones | 1 | 2012 | 15 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 512 | 0.020 |
Why?
|
| Exome | 1 | 2012 | 77 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 2046 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 1222 | 0.020 |
Why?
|
| Pedigree | 1 | 2012 | 195 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2012 | 113 | 0.020 |
Why?
|
| Axons | 1 | 2012 | 126 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2016 | 2140 | 0.020 |
Why?
|
| Europe | 1 | 2011 | 197 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2011 | 151 | 0.020 |
Why?
|
| Motor Neurons | 1 | 2012 | 215 | 0.020 |
Why?
|
| Actins | 1 | 2012 | 261 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 313 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2012 | 785 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 1597 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 1997 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2012 | 1160 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2011 | 856 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 2217 | 0.020 |
Why?
|